Apogee Therapeutics Inc (APGE)
R&D Expense Growth
10.66%
Quarterly · Period ending:
APGE R&D Expense Growth
Latest reported10.66%period ending
Latest reported10.66%period ending
APGE Quarterly R&D Growth (QoQ) (0.00% → 10.66%)
Latest values, visible window
High-resolution chart · PNG
APGE r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 10.6579% | |
| 4.0637% | |
| 7.874% | |
| -2.7377% | |
| 20.0832% | |
| -22.9823% | |
| 31.7518% | |
| 37.6679% | |
| 15.6359% | |
| -0.822% | |
| 69.6292% | |
| 22.3935% | |
| 64.9438% | |
| -30.7421% | |
| 23.5003% | |
| 582.6657% | |
| -65.8893% | |
| 0% |